4.1 Article

Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study

Yeva Sahakyan et al.

Summary: This study evaluated the cost-utility of minimally invasive therapies (MITs) compared to pharmacotherapy as initial treatment for patients with moderate-to-severe benign prostatic hyperplasia (BPH). The results showed that water vapor thermal therapy (WVTT) as initial treatment generated more quality-adjusted life years (QALYs) at a lower cost, making it an effective and cost-saving procedure.

PROSTATE CANCER AND PROSTATIC DISEASES (2023)

Article Economics

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force

Don Husereau et al.

Summary: The CHEERS 2022 statement replaces the previous reporting guidance and provides recommendations for accurate reporting and interpretation of health economic evaluations. It addresses different types of evaluations, new methods and developments, and includes stakeholder involvement. It is important for researchers, peer reviewers, editors, analysts, and health technology assessment bodies seeking guidance on reporting.

VALUE IN HEALTH (2022)

Article Multidisciplinary Sciences

A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia

Bilal Chughtai et al.

Summary: Treatment options for men with moderate-to-severe lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) have variable efficacy, safety, and retreatment profiles. This study found that water vapor thermal therapy (WVTT) is an effective and economically viable treatment for BPH from a US Medicare perspective.

PLOS ONE (2022)

Article Urology & Nephrology

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART IdInitial Work-up and Medical Management

Lori B. Lerner et al.

Summary: This article presents guidelines for effective management of male LUTS/BPH. By searching for the latest English language research studies and providing various levels of evidence to support different recommendations, a total of 19 guideline statements related to evaluation, work-up, and medical management were developed.

JOURNAL OF UROLOGY (2021)

Review Urology & Nephrology

Modern best practice in the management of benign prostatic hyperplasia in the elderly

Eric Bortnick et al.

THERAPEUTIC ADVANCES IN UROLOGY (2020)

Article Urology & Nephrology

Minimizing Sexual Dysfunction in BPH Surgery

Joon Yau Leong et al.

CURRENT SEXUAL HEALTH REPORTS (2019)

Article Health Care Sciences & Services

Health Technology Assessment and Its Use in Drug Policies: Singapore

Fiona Pearce et al.

VALUE IN HEALTH REGIONAL ISSUES (2019)

Article Health Care Sciences & Services

Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

James C. Ulchaker et al.

CLINICOECONOMICS AND OUTCOMES RESEARCH (2018)

Review Urology & Nephrology

An update on transurethral surgery for benign prostatic obstruction

Jonathan Shunming Teo et al.

ASIAN JOURNAL OF UROLOGY (2017)